It belongs to a class of drugs known as glucagon-like peptide-1 (GLP-1) agonists
dpp-4_inhibitors DPP-4 Inhibitors Sitagliptin Trade Name: Januvia Drug Class: oral hypoglycemics Mechanism of Action: An inhibitor of dipeptidyl peptidase-4 (DPP-4), a protease that degrades the incretin GLP-1 Incretins are hormones released from the GI tract in response to nutrient ingestion Incretins potentiate glucose-stimulated insulin secretion from beta cells in the pancreas As a result of inhibiting DPP-4, increased or prolonged GLP-1 levels are able to potentiate the secretion of insulin by the pancreas The effect produced by DPP-4 inhibitors is dependent on endogenous GLP-1 levels, and produce a modest effect on GLP-1 activity compared to giving GLP-1 receptor agonists (hence DPP-4 inhibitors do not have the same impact to produce weight loss as GLP-1 agonists)
Research into predictive biomarkers could improve patient selection and treatment monitoring
A study investigating the impact of resveratrol on glucose revealed that resveratrol can enhance glucose regulation and insulin sensitivity in diabetic rats (564)
Cyanocobalamin, also known as Vitamin B12, is essential for energy production, nerve function, and red blood cell formation
GLP-1R ECD and Fab 3F52 was mixed 1:1 and the complex was purified by size exclusion chromatography
